Европейский союз - итальянский - EMA (European Medicines Agency)

incyte biosciences distribution b.v. - ponatinib - leukemia, myeloid; leukemia, lymphoid - antineoplastic agents, protein kinase inhibitors - iclusig is indicated in adult patients withchronic phase, accelerated phase, or blast phase chronic myeloid leukaemia (cml) who are resistant to dasatinib or nilotinib; who are intolerant to dasatinib or nilotinib and for whom subsequent treatment with imatinib is not clinically appropriate; or who have the t315i mutationphiladelphia chromosome positive acute lymphoblastic leukaemia (ph+ all) who are resistant to dasatinib; who are intolerant to dasatinib and for whom subsequent treatment with imatinib is not clinically appropriate; or who have the t315i mutation. vedi sezioni 4. 2 assessment of cardiovascular status prior to start of therapy and 4. 4 situations where an alternative treatment may be considered.

Швейцария - итальянский - Swissmedic (Swiss Agency for Therapeutic Products)

incyte biosciences international sàrl - ponatinibum - compresse rivestite con film - ponatinibum 15 mg per ponatinibi hydrochloridum, excipiens pro compresso haze. - agente antineoplastico - synthetika

Швейцария - итальянский - Swissmedic (Swiss Agency for Therapeutic Products)

incyte biosciences international sàrl - ponatinibum - compresse rivestite con film - ponatinibum 45 mg per ponatinibi hydrochloridum, excipiens pro compresso haze. - agente antineoplastico - synthetika

Швейцария - итальянский - Swissmedic (Swiss Agency for Therapeutic Products)

incyte biosciences international sàrl - ponatinibum - compresse rivestite con film - ponatinibum 30 mg a ponatinibi hydrochloridum, excipiens pro compresso haze. - agente antineoplastico - synthetika

Италия - итальянский - AIFA (Agenzia Italiana del Farmaco)

ibsa farmaceutici italia s.r.l. - omega-3-trigliceridi inclusi altri esteri e acidi - omega-3-trigliceridi inclusi altri esteri e acidi

Италия - итальянский - Ministero della Salute

pan medical ltd - cateteri da occlusione vascolare

Италия - итальянский - Ministero della Salute

pan medical ltd - cateteri da occlusione vascolare

Италия - итальянский - Ministero della Salute

pan medical ltd - cateteri da occlusione vascolare

Италия - итальянский - Ministero della Salute

iso med - cateteri da occlusione vascolare

Италия - итальянский - Ministero della Salute

bayer ag - spirotetramat; - sospensione concentrata - 4.53 g i valori indicati sono per 100 g di prodotto. - spirotetramat; 4.53%; (48; g/l) - insetticida